Attendees at the 10th Annual PRO & eCOA Congress in Boston last month reaffirmed the need to use electronic clinical outcome assessment (COA) Systems as recommended by the FDA PRO Guidance to improve clinical research and gain regulatory approvals.
The PRO & eCOA Congress, hosted by PHT Corporation, is the premier PRO and eClinical outcome assessment meeting. It is attended by pharmaceutical and biotechnology professionals in clinical operations, outsourcing, data management, eClinical technologies, regulatory affairs, and health outcomes as well as PRO and eCOA thought leaders, regulators and sites. Help employers find you! Check out all the jobs and post your resume.
